Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Jun 2, 2011

30071_dirs_2011-06-02_d5896035-ced3-4ff3-982c-de79d229312f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-05-31

Reporting Person: Douglas Robert Andrew (COO Asia Pacific)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-31 ResMed Common Stock M 20000 $15.52 Acquired 55271.563 Direct
2011-05-31 ResMed Common Stock S 20000 $32.10 Disposed 35271.563 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-31 ResMed Common Stock Options $15.52 M 20000 Disposed 2015-11-20 ResMed Common Stock (20000) Direct

Footnotes

F1: Represents first date shares became exercisable.

F2: Includes 514.993 shares purchased on April 29, 2011, pursuant to ResMed's Employee Stock Purchase Plan.